Latest Breaking News On - Zyversa therapeutics - Page 2 : comparemela.com

ZyVersa Therapeutics Stock Jumps 8%

Shares of ZyVersa Therapeutics, Inc. (ZVSA) gained nearly 8% on Monday morning after the clinical stage specialty biopharmaceutical company announced that acclaimed inflammasome researchers from the University of Miami Miller School of Medicine and inventors of Inflammasome ASC Inhibitor IC 100, have published a scientific paper in the peer-reviewed journal, Frontiers in Molecular Neuroscience, highlighting how inflammasome-mediated inflammation in Alzheimer's disease can trigger inflammation in the heart.

United statesUniversity of miami miller school medicineZyversa therapeutics incZyversa therapeuticsMiami miller schoolMolecular neuroscience

ZyVersa Therapeutics (ZVSA) Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes

ZyVersa Therapeutics (ZVSA) Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stephenc gloverZyversa therapeutics incBiophysical research communicationsZyversa therapeuticsBiophysical research

ZyVersa Therapeutics Highlights Published Data

Inhibiting inflammasome pathways has potential to attenuate atherosclerosis in patients with diabetes, a leading cause of morbidity & mortality..

Stephenc gloverZyversa therapeutics incBiophysical research communicationsSecurities exchangeVersa therapeuticsBiophysical researchZyversa therapeuticsCholesterol efflux mediatorSecurities exchange actPrivate securities litigation reform actNasdaq zvsaZyversa therapeuticsNflammasome inhibitionNflammasome asc inhibitor

HC Wainwright Comments on ZyVersa Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:ZVSA)

HC Wainwright Comments on ZyVersa Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:ZVSA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Zyversa therapeutics incExchange commissionWalleye capitalZyversa therapeuticsFree reportZyversa therapeuticGet free reportVersa therapeuticsZyversa therapeutics daily

CEO Of This Leading Biotech Speaks To The Critical Nature Inflammation Plays In The Body

Stephen C. Glover, co-founder, chairman, CEO and president of ZyVersa Therapeutics Inc. ZVSA, was recently a panelist at Benzinga's Virtual HealthCare Summit…

Stephenc gloverZyversa therapeutics incZyversa therapeuticsVirtual healthcare summitReaking news